
ZYME
Healthcare · Biotechnology · $1.85B market cap
$26.24-0.23 (-0.9%)Nov 13, 4:20 PM EST
Next report
After the close
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +4.1% over 90 days · 30-day revisions 2 up, 1 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Mar 4, 2027 · upcoming | After the close | 0.08 | — | — |
| Nov 9, 2026 | After the close | 2.40 | 2.28 | -5.0% |
| Aug 6, 2026 | After the close | -0.56 | -0.62 | -10.7% |
| May 7, 2026 | After the close | -0.10 | -0.59 | -490.0% |
| Mar 2, 2026 | Time not confirmed | -0.32 | -0.55 | -70.6% |
| Nov 6, 2025 | After the close | -0.32 | -0.26 | +18.8% |
| Aug 7, 2025 | After the close | -0.52 | 0.03 | +105.8% |
| May 8, 2025 | After the close | -0.70 | -0.30 | +57.1% |
| Mar 4, 2025 | Before the open | -0.09 | -0.31 | -236.2% |
| Oct 31, 2024 | After the close | -0.41 | -0.39 | +4.9% |
| Aug 1, 2024 | After the close | -0.31 | -0.49 | -58.1% |
| May 2, 2024 | After the close | -0.29 | -0.42 | -44.8% |
| Mar 6, 2024 | After the close | -0.43 |
Zymeworks Inc., a biotechnology company, develops biotherapeutics for the treatment of cancer, inflammation, and autoimmune diseases. The company's platforms include Azymetric multispecific antibody platform; Drug Conjugate platform that includes a suite of proprietary cytotoxins comprising topoisomerase and microtubulin inhibiting toxins, stable linkers, and conjugation technologies; EFECT platform, which consists…
| -0.20 |
| +53.5% |
| Nov 7, 2023 | After the close | -0.47 | -0.41 | +12.8% |
| Aug 10, 2023 | After the close | -0.47 | -0.76 | -61.7% |
| May 8, 2023 | After the close | -0.54 | -0.36 | +33.3% |
| Mar 7, 2023 | After the close | 4.84 | 4.65 | -3.9% |
| Nov 8, 2022 | After the close | -0.97 | -0.72 | +25.8% |
| Aug 4, 2022 | After the close | -0.94 | -0.97 | -3.2% |
| May 4, 2022 | After the close | -0.76 | -1.19 | -56.6% |
| Feb 24, 2022 | After the close | -1.14 | -0.76 | +33.3% |
| Nov 3, 2021 | After the close | -1.08 | -1.17 | -8.3% |
| Aug 4, 2021 | After the close | -1.04 | -1.31 | -26.0% |
| May 5, 2021 | After the close | -1.05 | -0.87 | +17.1% |
| Feb 24, 2021 | After the close | -1.22 | -0.74 | +39.3% |
| Nov 3, 2020 | After the close | -0.99 | -1.43 | -44.4% |
| Aug 5, 2020 | After the close | -0.87 | -0.77 | +11.5% |
| May 7, 2020 | After the close | -1.07 | -0.64 | +40.2% |
| Mar 2, 2020 | After the close | -0.88 | -1.66 | -88.6% |
| Nov 5, 2019 | After the close | -0.74 | -0.70 | +5.4% |
| Aug 2, 2019 | After the close | -0.60 | -0.86 | -43.3% |
| May 2, 2019 | After the close | -0.52 | -0.43 | +17.3% |
| Mar 6, 2019 | After the close | 0.10 | 0.29 | +190.0% |
| Nov 6, 2018 | After the close | -0.64 | -0.59 | +7.8% |
| Aug 1, 2018 | Before the open | -0.33 | -0.22 | +33.3% |
| May 1, 2018 | After the close | -0.67 | -0.83 | -23.9% |
| Mar 14, 2018 | After the close | -0.01 | -0.68 | -6700.0% |